cysteine and deoxycytidine

cysteine has been researched along with deoxycytidine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, IW; Kereiakes, JG; Saenger, EL; Wrede, DE1
Lohman, GJ; Stubbe, J; Wang, J1
Distler, AM; Hill, EG; Lemasters, JJ; Manevich, Y; Mieyal, JJ; Nieminen, AL; Qanungo, S; Shaner, B; Townsend, DM; Uys, JD1
Bi, D; Ding, K; Ding, S; Li, J; Liu, S; Lu, J; Niu, Z; Sun, L; Wu, F; Zhang, H; Zhao, Z1

Other Studies

4 other study(ies) available for cysteine and deoxycytidine

ArticleYear
Evaluation of radiochemical protectors using urinary deoxycytidine levels.
    International journal of radiation biology and related studies in physics, chemistry, and medicine, 1975, Volume: 28, Issue:2

    Topics: Animals; Cysteine; Deoxycytidine; Dose-Response Relationship, Radiation; Evaluation Studies as Topic; Female; Mercaptoethylamines; Organothiophosphorus Compounds; Propiophenones; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Serotonin; X-Rays

1975
Enhanced subunit interactions with gemcitabine-5'-diphosphate inhibit ribonucleotide reductases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Sep-04, Volume: 104, Issue:36

    Topics: Cysteine; Cytidine Diphosphate; Deoxycytidine; Enzyme Activation; Escherichia coli; Gemcitabine; Humans; Molecular Structure; Molecular Weight; Protein Binding; Protein Subunits; Ribonucleotide Reductases; Time Factors

2007
N-acetyl-L-cysteine sensitizes pancreatic cancers to gemcitabine by targeting the NFκB pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2014, Volume: 68, Issue:7

    Topics: Acetylcysteine; Animals; Apoptosis; Cell Line, Tumor; Cysteine; Deoxycytidine; Gemcitabine; Glutathione; Humans; Male; Mice; Mice, Nude; NF-kappa B; Oxidative Stress; Pancreatic Neoplasms; Signal Transduction; X-Linked Inhibitor of Apoptosis Protein

2014
A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer.
    PloS one, 2015, Volume: 10, Issue:12

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cluster Analysis; Cysteine; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Kinesins; Mice, Inbred BALB C; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleoside Diphosphate Reductase; RNA Interference; Trityl Compounds; Tumor Burden; Tumor Suppressor Proteins; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2015